E-LIB Suche - Ergebnisse für: Kagiava, A

1

Gene replacement therapy in two Golgi-retained CMT1X mutant..:

Kagiava, A ; Karaiskos, C ; Lapathitis, G...
https://discovery.ucl.ac.uk/id/eprint/10175938/1/1-s2.0-S2329050123001134-main.pdf. , 2023

Link: https://discovery.ucl.ac..

2

AAV9-mediated SH3TC2 gene replacement therapy targeted to S..:

Georgiou, E ; Kagiava, A ; Sargiannidou, I...
https://discovery.ucl.ac.uk/id/eprint/10178813/1/1-s2.0-S1525001623004525-main.pdf. , 2023

Link: https://discovery.ucl.ac..

3

Efficacy of AAV serotypes to target Schwann cells after int..:

Kagiava, A ; Richter, J ; Tryfonos, C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640002/. , 2021

Link: http://www.ncbi.nlm.nih...

4

AAV9-mediated Schwann cell-targeted gene therapy rescues a ..:

Kagiava, A ; Karaiskos, C ; Richter, J...
https://discovery.ucl.ac.uk/id/eprint/10124367/1/s41434-021-00250-0.pdf. , 2021

Link: https://discovery.ucl.ac..

5

Efficacy of AAV serotypes to target Schwann cells after int..:

A. Kagiava ; J. Richter ; C. Tryfonos...
https://doi.org/10.1038/s41598-021-02694-1. , 2021

Link: https://doi.org/10.1038/..

6

Gene replacement therapy in a model of Charcot-Marie-Tooth ..:

Schiza, N ; Georgiou, E ; Kagiava, A...
https://discovery.ucl.ac.uk/id/eprint/10072067/3/Schiza_awz064.pdf. , 2019

Link: https://discovery.ucl.ac..

7

Gene replacement therapy after neuropathy onset provides th..:

Kagiava, A ; Richter, J ; Tryfonos, C...
https://zenodo.org/record/3839275. , 2019

Link: https://zenodo.org/recor..

8

Gene replacement therapy after neuropathy onset provides th..:

Kagiava, A ; Richter, J ; Tryfonos, C...
https://discovery.ucl.ac.uk/id/eprint/10080259/3/Heslegrave%20Late%20Cx32KO%20treatment%2031-3-19.pdf. , 2019

Link: https://discovery.ucl.ac..

9

Golgi-retained Cx32 mutants interfere with gene addition th..:

Kyriakoudi, S ; Sargiannidou, I ; Kagiava, A..
https://discovery.ucl.ac.uk/id/eprint/10044682/1/Kyriakoudi%20HMG%20.pdf. , 2017

Link: https://discovery.ucl.ac..

10

Systemic inflammation disrupts oligodendrocyte gap junction..:

Olympiou, M ; Sargiannidou, I ; Markoullis, K...
https://discovery.ucl.ac.uk/id/eprint/10038803/1/s40478-016-0369-5.pdf. , 2016

Link: https://discovery.ucl.ac..

11

Gene replacement therapy in two Golgi-retained CMT1X mutant..:

Kagiava, Alexia ; Karaiskos, Christos ; Lapathitis, George...
Molecular Therapy - Methods & Clinical Development;30. , 2023

Link: https://hdl.handle.net/1..

12

Gene replacement therapy in two Golgi-retained CMT1X mutant..:

Kagiava, Alexia ; Karaiskos, Christos ; Lapathitis, George...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460951/. , 2023

Link: http://www.ncbi.nlm.nih...

13

A translatable RNAi-driven gene therapy silences PMP22/Pmp2..:

Stavrou, Marina ; Kagiava, Alexia ; Choudury, Sarah G...
https://www.repository.cam.ac.uk/handle/1810/339662. , 2022

Link: https://www.repository.c..

14

A translatable RNAi-driven gene therapy silences PMP22/Pmp2..:

Stavrou, Marina ; Kagiava, Alexia ; Choudury, Sarah G...
https://discovery.ucl.ac.uk/id/eprint/10149105/1/Zetterberg_A%20translatable%20RNAi-driven%20gene%20therapy.pdf. , 2022

Link: https://discovery.ucl.ac..

15

Aberrant Mitochondrial Dynamics and Exacerbated Response to..:

Stavropoulos, Filippos ; Sargiannidou, Irene ; Potamiti, Louiza...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584238/. , 2021

Link: http://www.ncbi.nlm.nih...